Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1986 2
1987 2
1989 2
1990 1
1992 2
1994 3
1995 2
1996 4
1997 2
1998 4
1999 4
2000 5
2001 3
2002 2
2003 2
2004 5
2005 8
2006 15
2007 15
2008 12
2009 8
2010 11
2011 13
2012 18
2013 15
2014 6
2015 17
2016 11
2017 15
2018 12
2019 19
2020 18
2021 18
2022 18
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Spatially mapping the immune landscape of melanoma using imaging mass cytometry.
Moldoveanu D, Ramsay L, Lajoie M, Anderson-Trocme L, Lingrand M, Berry D, Perus LJM, Wei Y, Moraes C, Alkallas R, Rajkumar S, Zuo D, Dankner M, Xu EH, Bertos NR, Najafabadi HS, Gravel S, Costantino S, Richer MJ, Lund AW, Del Rincon SV, Spatz A, Miller WH Jr, Jamal R, Lapointe R, Mes-Masson AM, Turcotte S, Petrecca K, Dumitra S, Meguerditchian AN, Richardson K, Tremblay F, Wang B, Chergui M, Guiot MC, Watters K, Stagg J, Quail DF, Mihalcioiu C, Meterissian S, Watson IR. Moldoveanu D, et al. Among authors: mes masson am. Sci Immunol. 2022 Apr;7(70):eabi5072. doi: 10.1126/sciimmunol.abi5072. Epub 2022 Apr 1. Sci Immunol. 2022. PMID: 35363543
Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.
Sauer CM, Hall JA, Couturier DL, Bradley T, Piskorz AM, Griffiths J, Sawle A, Eldridge MD, Smith P, Hosking K, Reinius MAV, Morrill Gavarró L, Mes-Masson AM, Ennis D, Millan D, Hoyle A, McNeish IA, Jimenez-Linan M, Martins FC, Tischer J, Vias M, Brenton JD. Sauer CM, et al. Among authors: mes masson am. Nat Commun. 2023 Oct 16;14(1):6505. doi: 10.1038/s41467-023-41840-3. Nat Commun. 2023. PMID: 37845213 Free PMC article.
Multi-size spheroid formation using microfluidic funnels.
Marimuthu M, Rousset N, St-Georges-Robillard A, Lateef MA, Ferland M, Mes-Masson AM, Gervais T. Marimuthu M, et al. Among authors: mes masson am. Lab Chip. 2018 Jan 16;18(2):304-314. doi: 10.1039/c7lc00970d. Lab Chip. 2018. PMID: 29211088
Ran GTPase: A Key Player in Tumor Progression and Metastasis.
Boudhraa Z, Carmona E, Provencher D, Mes-Masson AM. Boudhraa Z, et al. Among authors: mes masson am. Front Cell Dev Biol. 2020 May 26;8:345. doi: 10.3389/fcell.2020.00345. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32528950 Free PMC article. Review.
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene.
Fierheller CT, Alenezi WM, Serruya C, Revil T, Amuzu S, Bedard K, Subramanian DN, Fewings E, Bruce JP, Prokopec S, Bouchard L, Provencher D, Foulkes WD, El Haffaf Z, Mes-Masson AM, Tischkowitz M, Campbell IG, Pugh TJ, Greenwood CMT, Ragoussis J, Tonin PN. Fierheller CT, et al. Among authors: mes masson am. Genes (Basel). 2023 Jan 20;14(2):277. doi: 10.3390/genes14020277. Genes (Basel). 2023. PMID: 36833203 Free PMC article.
GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer.
Galan A, Papaluca A, Nejatie A, Matanes E, Brahimi F, Tong W, Hachim IY, Yasmeen A, Carmona E, Klein KO, Billes S, Dawod AE, Gawande P, Jeter AM, Mes-Masson AM, Greenwood CMT, Gotlieb WH, Saragovi HU. Galan A, et al. Among authors: mes masson am. Front Oncol. 2023 Apr 14;13:1134763. doi: 10.3389/fonc.2023.1134763. eCollection 2023. Front Oncol. 2023. PMID: 37124505 Free PMC article.
Signaling by the tyrosine kinase Yes promotes liver cancer development.
Guégan JP, Lapouge M, Voisin L, Saba-El-Leil MK, Tanguay PL, Lévesque K, Brégeon J, Mes-Masson AM, Lamarre D, Haibe-Kains B, Trinh VQ, Soucy G, Bilodeau M, Meloche S. Guégan JP, et al. Among authors: mes masson am. Sci Signal. 2022 Jan 18;15(717):eabj4743. doi: 10.1126/scisignal.abj4743. Epub 2022 Jan 18. Sci Signal. 2022. PMID: 35041461
Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy.
Henault D, Stephen D, St-Hilaire PA, Messaoudi N, Vandenbroucke-Menu F, Simoneau E, Rong Z, Plasse M, Létourneau R, Roy A, Dagenais M, Lapointe R, Nguyen B, Mes-Masson AM, Soucy G, Turcotte S. Henault D, et al. Among authors: mes masson am. Oncoimmunology. 2023 Sep 14;12(1):2253642. doi: 10.1080/2162402X.2023.2253642. eCollection 2023. Oncoimmunology. 2023. PMID: 37720689 Free PMC article.
Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.
Sauriol A, Carmona E, Udaskin ML, Radulovich N, Leclerc-Desaulniers K, Rottapel R, Oza AM, Lheureux S, Provencher DM, Mes-Masson AM. Sauriol A, et al. Among authors: mes masson am. Sci Rep. 2023 Feb 27;13(1):3334. doi: 10.1038/s41598-023-30081-5. Sci Rep. 2023. PMID: 36849518 Free PMC article.
289 results